» Articles » PMID: 39132687

OSA Diagnosis Goes Wearable: Are the Latest Devices Ready to Shine?

Overview
Specialties Neurology
Psychiatry
Date 2024 Aug 12
PMID 39132687
Authors
Affiliations
Soon will be listed here.
Abstract

Study Objectives: From 2019-2023, the United States Food and Drug Administration has cleared 9 novel obstructive sleep apnea-detecting wearables for home sleep apnea testing, with many now commercially available for sleep clinicians to integrate into their clinical practices. To help clinicians comprehend these devices and their functionalities, we meticulously reviewed their operating mechanisms, sensors, algorithms, data output, and related performance evaluation literature.

Methods: We collected information from PubMed, United States Food and Drug Administration clearance documents, ClinicalTrials.gov, and web sources, with direct industry input whenever feasible.

Results: In this "device-centered" review, we broadly categorized these wearables into 2 main groups: those that primarily harness photoplethysmography data and those that do not. The former include the peripheral arterial tonometry-based devices. The latter was further broken down into 2 key subgroups: acoustic-based and respiratory effort-based devices. We provided a performance evaluation literature review and objectively compared device-derived metrics and specifications pertinent to sleep clinicians. Detailed demographics of study populations, exclusion criteria, and pivotal statistical analyses of the key validation studies are summarized.

Conclusions: In the foreseeable future, these novel obstructive sleep apnea-detecting wearables may emerge as primary diagnostic tools for patients at risk for moderate-to-severe obstructive sleep apnea without significant comorbidities. While more devices are anticipated to join this category, there remains a critical need for cross-device comparison studies as well as independent performance evaluation and outcome research in diverse populations. Now is the moment for sleep clinicians to immerse themselves in understanding these emerging tools to ensure our patient-centered care is improved through the appropriate implementation and utilization of these novel sleep technologies.

Citation: Chiang AA, Jerkins E, Holfinger S, et al. OSA diagnosis goes wearable: are the latest devices ready to shine? . 2024;20(11):1823-1838.

Citing Articles

Responses to questions about Sunrise in the review on OSA wearables by Chiang et al.

Martinot J, Le-Dong N J Clin Sleep Med. 2024; 21(2):451-452.

PMID: 39484815 PMC: 11789239. DOI: 10.5664/jcsm.11458.

References
1.
Hilmisson H, Berman S, Magnusdottir S . Sleep apnea diagnosis in children using software-generated apnea-hypopnea index (AHI) derived from data recorded with a single photoplethysmogram sensor (PPG) : Results from the Childhood Adenotonsillectomy Study (CHAT) based on cardiopulmonary.... Sleep Breath. 2020; 24(4):1739-1749. DOI: 10.1007/s11325-020-02049-6. View

2.
Pepin J, Letesson C, Le-Dong N, Dedave A, Denison S, Cuthbert V . Assessment of Mandibular Movement Monitoring With Machine Learning Analysis for the Diagnosis of Obstructive Sleep Apnea. JAMA Netw Open. 2020; 3(1):e1919657. PMC: 6991283. DOI: 10.1001/jamanetworkopen.2019.19657. View

3.
Montazeri Ghahjaverestan N, Fan W, Aguiar C, Yu J, Bradley T . Respiratory Motion and Airflow Estimation During Sleep Using Tracheal Movement and Sound. Nat Sci Sleep. 2022; 14:1213-1223. PMC: 9255718. DOI: 10.2147/NSS.S360970. View

4.
Argod J, Pepin J, Levy P . Differentiating obstructive and central sleep respiratory events through pulse transit time. Am J Respir Crit Care Med. 1998; 158(6):1778-83. DOI: 10.1164/ajrccm.158.6.9804157. View

5.
Bandyopadhyay A, Bae C, Cheng H, Chiang A, Deak M, Seixas A . Smart sleep: what to consider when adopting AI-enabled solutions in clinical practice of sleep medicine. J Clin Sleep Med. 2023; 19(10):1823-1833. PMC: 10545999. DOI: 10.5664/jcsm.10702. View